StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 94M, up 4.8% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is 94M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202594M+4.8%
FY2024Dec 31, 202490M+2.2%
FY2023Dec 31, 202388M+1.2%
FY2022Dec 31, 202287M+2.8%
FY2021Dec 31, 202184M+5.8%
FY2020Dec 31, 202080M+25.1%
FY2019Dec 31, 201964M+15.1%
FY2018Dec 31, 201855M+8.0%
FY2017Dec 31, 201751M+0.6%
FY2016Dec 31, 201651M+0.8%
FY2015Dec 31, 201550M+4.2%
FY2014Dec 31, 201448M+24.5%
FY2013Dec 31, 201339M+7.2%
FY2012Dec 31, 201236M+5.8%
FY2011Dec 31, 201134M+3.0%
FY2010Dec 31, 201033M–

More Compugen figures

See a number that looks wrong?